<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta name=Title content="WOMEN AT RISK: EMBRYONIC AND FETAL STEM CELL RESEARCH">
<meta name=Keywords content="">
<meta http-equiv=Content-Type content="text/html; charset=macintosh">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 10">
<meta name=Originator content="Microsoft Word 10">
<link rel=File-List href="abstractBAYLISMCINNES_files/filelist.xml">
<title>WOMEN AT RISK: EMBRYONIC AND FETAL STEM CELL RESEARCH</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>Simon Grant</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>Simon Grant</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>0</o:TotalTime>
  <o:Created>2007-04-06T03:58:00Z</o:Created>
  <o:LastSaved>2007-04-06T03:58:00Z</o:LastSaved>
  <o:Pages>1</o:Pages>
  <o:Words>203</o:Words>
  <o:Characters>1158</o:Characters>
  <o:Lines>9</o:Lines>
  <o:Paragraphs>2</o:Paragraphs>
  <o:CharactersWithSpaces>1422</o:CharactersWithSpaces>
  <o:Version>10.260</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:Zoom>120</w:Zoom>
  <w:DisplayHorizontalDrawingGridEvery>0</w:DisplayHorizontalDrawingGridEvery>
  <w:DisplayVerticalDrawingGridEvery>0</w:DisplayVerticalDrawingGridEvery>
  <w:UseMarginsForDrawingGridOrigin/>
 </w:WordDocument>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
@font-face
	{font-family:Arial;
	panose-1:0 2 11 6 4 2 2 2 2 2;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:50331648 0 0 0 1 0;}
@font-face
	{font-family:"Arial Black";
	panose-1:0 2 11 10 4 2 1 2 2 2;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:50331648 0 0 0 1 0;}
@font-face
	{font-family:Georgia;
	panose-1:0 2 4 5 2 5 4 5 2 3;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:50331648 0 0 0 1 0;}
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Arial;}
h1
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	mso-pagination:none;
	page-break-after:avoid;
	mso-outline-level:1;
	mso-layout-grid-align:none;
	text-autospace:none;
	font-size:14.0pt;
	font-family:Georgia;
	mso-font-kerning:0pt;
	font-weight:normal;}
p.MsoToc1, li.MsoToc1, div.MsoToc1
	{mso-style-update:auto;
	mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Arial;}
p.Topic, li.Topic, div.Topic
	{mso-style-name:Topic;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Arial Black";}
p.Case, li.Case, div.Case
	{mso-style-name:Case;
	mso-style-update:auto;
	mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Arial;
	font-weight:bold;}
@page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1027"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body bgcolor=white lang=EN-US style='tab-interval:.5in'>

<div class=Section1>

<p class=MsoNormal align=center style='text-align:center;mso-pagination:none;
mso-layout-grid-align:none;text-autospace:none'><span style='font-size:14.0pt;
font-family:Georgia'>WOMEN AT RISK: EMBRYONIC AND FETAL STEM CELL RESEARCH<o:p></o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;mso-pagination:none;
mso-layout-grid-align:none;text-autospace:none'><span style='font-size:14.0pt;
font-family:Georgia'>IN CANADA<o:p></o:p></span></p>

<p class=MsoNormal style='mso-pagination:none;mso-layout-grid-align:none;
text-autospace:none'><span style='font-family:Georgia'><i>Françoise Baylis</i></span><span
style='font-size:6.5pt;font-family:Georgia'><o:p></o:p></span></p>

<p class=MsoNormal style='mso-pagination:none;mso-layout-grid-align:none;
text-autospace:none'><span style='font-family:Georgia'><i>&amp; Caroline
McInnes</i></span><span style='font-size:6.5pt;font-family:Georgia'><o:p></o:p></span></p>

<p class=MsoNormal style='mso-pagination:none;mso-layout-grid-align:none;
text-autospace:none'><span style='font-size:8.0pt;font-family:Georgia'><i><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></i></span></p>

<p class=MsoNormal style='mso-pagination:none;mso-layout-grid-align:none;
text-autospace:none'><span style='font-size:8.0pt;font-family:Georgia'><i>In
March of 2002, in the absence of explicit Canadian law or policy regulating the
burgeoning and ethically controversial field of human embryonic stem cell
research, the Canadian Institutes of Health Research (CIHR) published its
Guidelines for Human Pluripotent Stem Cell Research. These Guidelines—largely
based on the recommendations of CIHR’s ad hoc Working Group on Stem Cell
Research—aimed to enable the advancement of the stem cell science whilst
protecting and promoting the interests of research participants, most
particularly women. Unfortunately, as detailed in this paper, some of the ad
hoc Working Group’s recommendations specifically aimed at shielding women from
potential coercion and exploitation were either omitted or amended, absent
stated authority, in the 2002 Guidelines as later amended in 2005 and 2006.
This paper traces the omissions and amendments to key recommendations on: (i)
free and informed consent to research participation; (ii) decision-making
regarding the future disposition of unwanted embryos; (iii) potential conflicts
of interest; and (iv) the research use of frozen embryos. Concerns are raised
about the consequences of the changes made to the protection and promotion of
women’s interests and the lack of legitimate authority for some of the changes.</i></span><span
style='font-family:Georgia'><o:p></o:p></span></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

</div>

</body>

</html>
